Compositions containing glycosylated molecules having human tissue type plasminogen activator enzymatic activity
作者： Rainer Rudolph , Ulrich Kohnert
DOI:
关键词:
摘要: The invention is a pharmaceutical composition containing glycosylated protein having human tissue type plasminogen activator activity of at least 1.4 MU/ml, citrate, and one number various compounds. has pH ranging from 4.5 to 9.
lens.org 参考文章(17)
H. Eser Tolunay, Mark O. Palmier, Ernest J. Mayer, Thomas G. Warren, Leslie D. Bell, Tze-Chein Wun, Modified tissue plasminogen activator K2K2SP ,(1988)
Daniel T. Connolly, Joseph Feder, Jon P. Schaumann, Nicholaos K. Harakas, Arthur J. Wittwer, Large scale production of plasminogen activator from normal human colon cells ,(1986)
Michael D. Johnston, Henry Berger, Low pH pharmaceutical formulation containing t-PA ,(1986)
Benjamin S. Isaacs, Himakshi Middlesex Street Patel, Pharmaceutical formulations of plasminogen activator proteins ,(1990)
Thomas Robert Malefyt, Chester Allen Meyers, Pharmaceutical dosage unit ,(1986)
Naoki Asakawa, Yasuo Ishibashi, Yasuo Miyake, Fumio Kakimoto, tPA-containing medical composition ,(1987)
William R. Tolbert, Joseph Feder, Raymond A. Dwek, Thomas W. Rademacher, Raj B. Parekh, Tissue plasminogen activator from normal human colon cells ,(1986)
Hans-Arnold Stohr, Eric P. Paques, t-PA solution of high concentration and use of the solution in human and veterinary medicine ,(1988)
Shuhei Kondo, Akio Hasegawa, An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method ,(1985)
Stuart Elliot Builder, William Franklin Bennett, Larry Alan Gatlin, Stabilized human tissue plasminogen activator compositions ,(1986)